C.H. Robinson Worldwide, Inc. entered into a Delayed Draw Term Loan Credit Agreement on November 19, 2026, to support its acquisition of RXO, Inc. The agreement establishes a senior unsecured delayed draw term loan facility with a maximum aggregate principal amount of $500 million. This loan is designed to be drawn in a single borrowing on the date the RXO Acquisition is completed and matures two years after that funding date.
The loan facility is governed by U.S. Bank National Association, which serves as the administrative agent. The obligations under the agreement are guaranteed by certain of the Company’s material domestic subsidiaries. The terms of the loan include interest options based on Term SOFR or a base rate, with margins ranging from 0% to 1.375% depending on the Company's credit ratings from S&P and Moody’s. Additionally, the Company will pay a ticking fee ranging from 0.07% to 0.15% per annum on undrawn commitments, accruing from February 1, 2027.
Financial covenants included in the agreement require the Company to maintain a net leverage ratio of not more than 4.25 to 1.00 during the first four fiscal quarters following the funding date, and not more than 3.75 to 1.00 thereafter. The loan is subject to limited conditions, including the consummation of the RXO Acquisition and the repayment of RXO’s existing asset-based revolving credit facility.
In related financing updates, the Company also entered into the Seventh Amendment to its Receivables Purchase Agreement on November 18, 2026. This amendment reassigns the administrative agent role from Bank of America, N.A. to Wells Fargo Bank, National Association. It also adjusts the commitments under the facility to $300 million for Bank of America and $450 million for Wells Fargo, resulting in a total committed funding of $750 million. The amendment extends the scheduled purchase termination date of the facility to November 17, 2028.